COVID-19 Health Evidence Summary No.53 by Millington, Kerry & Reddin, Samantha
   
1 
Evidence Summary 
y 
 
 
COVID-19  
Health Evidence Summary No.53 
Kerry Millington & Samantha Reddin 
Liverpool School of Tropical Medicine (LSTM) & Institute of Development Studies 
03 June 2020  
 
This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of available evidence on COVID-19 but aims to make original documents easily accessible to 
decision makers which, if relevant to them, they should go to before making decisions.   
 
Clinical characteristics and management 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
02.06.20 Clinical 
features of 
COVID-19 
patients in 
Abdul 
Wahab 
Sjahranie 
Hospital, 
Samarinda, 
Indonesia 
medRxiv | 
Preprint (not 
peer reviewed) 
 The majority of COVID-19 
patients are male. COVID-
19 comorbidities were 
found in several patients. 
The main clinical 
symptoms of COVID-19 in 
this study were cough, 
sore throat, and fever.  
 The abnormal laboratory 
finding in COVID-19 
patients is anemia, an 
increase in AST and ALT 
levels, and chest x-ray 
images of pneumonia. All 
patients are in mild 
condition. The average 
length of hospital 
admission patients to 
discharge is more than 30 
days.  
 The inability of a local 
laboratory to check for 
positive confirmation of 
COVID-19 makes the 
admission period of the 
patient in the hospital very 
 Morbidity 
2 
long. The availability of RT-
PCR tests at Abdul Wahab 
Sjahranie Hospital 
Samarinda will greatly 
assist the further 
management of COVID-19 
patients.. 
Epidemiology and modelling  
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
02.06.20 Effects of non-
pharmaceutical 
interventions 
on COVID-19 
cases, deaths, 
and demand 
for hospital 
services in the 
UK: a 
modelling 
study 
(Included for 
possible 
lessons learnt 
and projections 
relevant for 
LMIC) 
Lancet | 
Article 
 This study assesses the 
potential impact of 
different control measures 
for mitigating the burden 
of COVID-19 in the UK. 
 The four base 
interventions modelled 
were school closures, 
physical distancing, 
shielding of people aged 
70 years or older, and 
self-isolation of 
symptomatic cases. 
 Conclusion that intensive 
interventions with 
lockdown periods would 
need to be in place for a 
large proportion of the 
coming year to prevent 
health-care demand 
exceeding availability. 
Modelling,  
 
 
Infection Prevention and Control 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
 01.06.20 Predicting 
infectious 
SARS-CoV-2 
from diagnostic 
samples 
 Clinical 
Infectious 
Diseases | 
Accepted 
manuscript 
 People with COVID-19 
are unlikely to spread the 
new coronavirus if more 
than eight days have 
passed since their 
symptoms began, 
according to experiments 
in monkey cells. 
Public 
Health, 
Isolation 
3 
 Hospital patients who still 
test positive for viral RNA 
weeks after they began 
feeling ill might not need 
to be strictly isolated. 
 
Therapeutics 
Public
ation 
date 
Title/URL Journal/
Article 
type 
Summary             Keywords 
02.06.
20 
G6PD variant 
distribution in sub-
Saharan Africa and 
potential risks of 
using 
chloroquine/hydroxy
chloroquine based 
treatments for 
COVID-19 
medRxiv 
| Preprint 
(not peer 
reviewed
) 
 Chloroquine/hydro
xychloroquine 
have been 
proposed as 
potential 
treatments for 
COVID-19. These 
drugs have 
warning labels for 
use in individuals 
with glucose-6-
phosphate 
dehydrogenase 
(G6PD) 
deficiency. 
Analysis of whole-
genome 
sequence data of 
458 individuals 
from sub-Saharan 
Africa showed 
significant G6PD 
variation across 
the continent. 
 The high 
prevalence of 
variants in the 
G6PD gene found 
in this analysis 
suggests that it 
may be a 
significant 
interaction factor 
in clinical trials of 
chloroquine and 
hydrochloroquine 
for treatment of 
COVID-19 in 
Africans. 
Drug, 
Chloroquine/hydrox
ychloroquine 
4 
Social Science 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
02.06.20 Public 
Knowledge 
and 
Practices 
regarding 
COVID-19: A 
cross-
sectional 
survey from 
Pakistan 
medRxiv | 
Preprint (not 
peer reviewed) 
 Pakistani residents had 
good knowledge and 
practices towards COVID-
19 yet there are gaps in 
specific aspects of 
knowledge, and practice 
that should be focused in 
future awareness and 
educational campaigns.  
 Study recommends the 
ministry of health 
authorities promote all 
precautionary and 
preventive measures of 
COVID-19 - to all strata of 
society including less 
privileged people, older 
ones and less educated 
people. 
equity 
Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | Article type Author(s) 
02.06.20 Hydroxychloroquine or chloroquine 
with or without a macrolide for 
treatment of COVID-19: a multinational 
registry analysis 
Lancet | Expression of 
concern 
  
June 2020 Initiation of the Global Coalition for 
Radiotherapy during the COVID-19 
pandemic 
Lancet Oncology | 
Comment 
Pat Price, 
Shandi E 
Barney 
02.06.20 Global mental health and COVID-19 Lancet Psychiatry | 
Comment 
Lola Kola 
02.06.20 The need for privacy with public digital 
contact tracing during the COVID-19 
pandemic 
Lancet Digital Health | 
Comment 
Yoshua 
Bengio, 
Richard 
Janda et al 
5 
02.06.20 Thousands of people will help 
scientists to track the long-term health 
effects of the coronavirus crisis 
Nature |News   
02.06.20 A Harm-Reduction Approach to 
Coronavirus Disease 2019 (COVID-
19)—Safer Socializing 
JAMA Health Forum | 
Insights 
Eric 
Kutscher, 
Richard E. 
Greene 
26.05.20 Why Africa struggles to test for covid-
19 
The Economist | News   
Guidelines, Statements & Tools 
Publication 
Date 
Title/URL Source   Summary 
01.06.20 Basic Psychosocial 
Skills: A Guide for 
COVID-19 
Responders 
WHO 
 This Guide aims to help orient people 
supporting the COVID-19 response to 
integrate psychosocial support skills 
into their daily work, thereby making 
a difference to the well-being of 
people they come into contact with 
during the pandemic.  
 The guide advises how to help others 
find their own solutions to their 
problems. 
Dashboards & Trackers 
Cases & 
deaths: 
Global 
Cases & 
deaths: 
Regional 
Cases & 
deaths: 
Country 
Living 
evidence 
& policy 
maps 
Current 
research 
including trials 
  Diagnosti
cs 
  Treatment
s 
  Vaccin
es 
WHO 
sitreps 
WHO 
Africa 
Ghana COVID-
NMA 
WHO   FIND 
SARS-
CoV-2 Test 
Tracker 
  Global 
COVID-19 
Clinical 
Trial 
Tracker 
  CEPI 
6 
WHO 
dashboard 
African 
Argumen
ts 
Indonesi
a 
EPPI 
Centre 
WHO 
International 
Clinical Trials 
Registry 
Platform 
(ICTRP) 
 FIND 
SARS-
CoV-2 
Diagnostic
s: 
performanc
e data 
  US NIH 
registered 
clinical 
trials 
Vaccine 
Centre 
LSHTM 
Johns 
Hopkins 
University 
Europea
n CDC 
Nigeria 
CDC 
Norwegian 
Institute of 
Public 
Health 
Cytel  Serology-
based 
tests for 
COVID-19 
  Solidarity 
trial 
 COVID-
19 
Oxford 
Vaccine 
Trial 
WEF 
  Sierra 
Leone 
 Oxford 
C19 
Governme
nt 
Response 
Tracker 
(OxCGRT) 
US NIH  Our World 
in Data: 
C19 
Testing 
  COVID-
19 
Therapeuti
cs 
Accelerator 
  
Our World 
in Data 
  Singapor
e 
 Our World 
in Data: 
C19 Policy 
responses 
COVID-
evidence 
      
Global 
5050 
  UK  IFPRI 
COVID-19 
Policy 
Response 
Portal 
Cochrane       
CEBM, 
University 
of Oxford 
  US   Clinicaltrials.g
ov 
      
Humanitari
an Data 
Exchange 
       UKCDR       
Information 
is Beautiful 
              
7 
LSHTM               
HealthMap 
(cases) 
              
The 
Commons 
Project 
              
C19 Resource Hubs 
Global  Regional 
& Country 
Academi
c 
journals 
& 
Publisher
s 
Institutes/Centres/Funders/
Other 
Health 
Topics 
  Social 
Sciences 
WHO 
COVID-19 
pandemic  
Africa 
CDC 
Annals of 
Internal 
Medicine 
LSTM Stop TB 
Partnership 
  SSHAP 
WHO risk 
communicati
on 
African 
Union 
BMJ LSHTM 
 
  IDA 
WHO Q&A Nigeria 
CDC 
Bulletin 
of the 
WHO 
ICL MRC Centre for Global 
Infectious Disease Analysis  
Global 
Menstrual 
Collective  
  Disability 
and 
inclusion 
WHO Global 
research 
GeoPoll: 
SSA 
Cambrid
ge 
Universit
y Press 
ODI SLH: 
Handwashi
ng in low 
resource 
settings 
  Coregrou
p IDDC 
COVID-19 
Solidarity 
Response 
Fund 
Global 
Health 
Network 
Africa 
Cell 
Press 
Johns Hopkins University RBM 
Partnership 
  Ethics, 
health 
systems & 
COVID-19 
8 
UN African 
Academy 
of 
Sciences 
Cochran
e  
Center for Global 
Development 
    Social 
Developm
ent Direct 
C19 blog 
series 
UN Women Africa 
Evidence 
Network 
Elsevier CMMID Repository     
UNOCHA OCHA 
Southern 
and 
Eastern 
Africa 
COVID-19 
Digest 
JAMA 
Network 
Norwegian Institute of 
Public Health 
    
UNHCR  South 
African 
Governme
nt 
The 
Lancet 
Oxford Centre for 
Evidence-based Medicine 
    
UNICEF   medRxiv 
and 
bioRxiv 
(Preprint
s) 
 HEART     
UNESCO   NEJM  UKRI     
UN WFP   Oxford 
Universit
y Press 
 Evidence Aid     
GOARN   PLoS  NIH     
EPI-WIN   SAGE 
journals 
IFPRI Resources and 
Analyses of C19 Impact 
    
World Bank   Science  Prevent Epidemics      
9 
Our World in 
Data 
  Springer 
Nature 
      
COVID-19 
Narratives by 
David 
Nabarro 
  SSRN 
(Preprint
s)  
      
Reliefweb   Wiley       
Humanitarian 
OpenStreetM
ap Team 
          
Global 
Partnership 
for 
Sustainable 
Development 
Data 
  
 
      
WorldPop           
Flowminder           
COVID-END           
Premise 
COVID-19 
Global 
Impact Study 
    
  
  
10 
Online learning & events 
Date Title/URL Online 
learning/event 
Duration Lead 
03.06.20 
2-3pm 
Alumni webinar #5 - 
Corona in Kenya: 
interventions, 
challenges, lessons 
learnt and the way 
forward 
Virtual event I hour ITM 
Available 
now 
Standard precautions: 
Environmental 
cleaning and 
disinfection 
Online course I hour WHO 
16.06.2020 Africa beyond COVID-
19 
Virtual event 1h 30 
hours 
ODI 
15.06.2020 Poverty monitoring in 
the context of Covid-
19 
Virtual event 1h 15 ODI 
Available 
now 
COVID-19: Effective 
Nursing in Times of 
Crisis 
Online course 2 weeks – 
2 hours per 
week 
Johns Hopkins School 
of Nursing 
04.06.2020 
12pm ET 
CGD Conversations 
on COVID-19 and 
Development: John 
Nkengasong 
Event   CGD 
Available 
now 
WHO Academy and 
WHO Info mobile 
applications 
Mobile app   WHO 
Available 
now 
COVID-19: 
Pandemics, Modelling 
and Policy 
Online 
learning 
2 weeks | 2 
hours 
weekly 
study 
FutureLearn UNESCO 
UNITWIN Complex 
Systems Digital 
Campus/Open 
University 
11 
11.5.2020 COVID-19 Contact 
Tracing course 
Online 
learning 
5 hours Johns Hopkins 
Bloomberg School of 
Health 
7-28 May 
2020 
Virtual Evidence 
Weeks 
5 sessions 1h 30 International Initiative 
for Impact Evaluation 
(3ie) 
Tuesdays at 
1700 CEST 
(Geneva 
time) & 
Thursdays 
0830 CEST 
(Geneva 
time) 
COVID-19 Open 
online brief with Dr 
David Nabarro 
Event 1h 4SD 
30.04.2020 Professor Chris 
Whitty’s Gresham 
lecture on COVID-19 
Event 1h 20 Gresham College 
Available 
now 
Emerging respiratory 
viruses, including 
COVID-19: methods 
for detection, 
prevention, response 
and control 
Online 
learning 
3 hours WHO 
Available 
now 
Responding to 
COVID-19: Real-time 
training for the 
coronavirus disease 
outbreak 
Online 
learning 
Multiple 
self-paced 
course 
WHO 
25 May 
2020 
COVID-19: Tackling 
the Novel Coronavirus 
Online 
learning 
3 weeks | 4 
hours 
weekly 
study 
FutureLearn 
LSHTM/UK PHRST 
Available 
online now 
without 
mentors. 
Updated 
COVID-19 
Diagnostics and 
Testing 
Online 
learning 
3 weeks | 3 
hours 
weekly 
study 
FutureLearn 
FIND/LSHTM/ASLM 
12 
version will 
commence 
early June 
2020 
6 April 2020 COVID-19 Critical 
Care: Understanding 
and Application 
Online 
learning 
5 weeks | 1 
hour 
weekly 
study 
FutureLearn University 
of Edinburgh & Royal 
College of Physicians 
of Edinburgh  
Available 
now 
COVID-19 supporting 
online courses 
Online 
learning 
Multiple 
self-paced 
course 
BMJ Learning 
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Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa”) OR (“equity” OR “equities”) OR (“poverty”), restricted to 
articles published in the previous 2 to 3 days, in English. This is complemented by a search of the homepage of 
the following high-impact global health journals: The Lancet journals, New England Journal of Medicine, Nature, 
JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ Global Health, the PLoS journals and a Twitter 
search of their Twitter pages. A search also of preprints from bioRxiv and medRxiv. Please note that papers that 
have not been peer-reviewed are highlighted in red. All primary research papers that relate to the primary and 
secondary impacts of the COVID-19 response in LMICs, and disease control and health system responses are 
included. Articles related to tackling the secondary impacts on other sectors are not included. Additional 
commentaries, opinions, and commissioned pieces are selected based on relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
About this report 
This daily COVID-19 health evidence summary (HES) is based on 3 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before 
making decisions. The HES are not intended to replace medical or professional advice and the researcher or the 
K4D consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES 
alone. K4D services are provided by a consortium of leading organisations working in international development, 
led by the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds 
Nuffield Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), 
13 
University of Birmingham International Development Department (IDD) and the University of Manchester 
Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. 
It is licensed for non-commercial purposes only. K4D cannot be held responsible for 
errors, omissions or any consequences arising from the use of information contained in 
this health evidence summary. Any views and opinions expressed do not necessarily 
reflect those of DFID, K4D or any other contributing organisation.  
© DFID - Crown copyright 2020. 
 
